-
1
-
-
78349271737
-
Gender differences in treatment of cardiovascular disease: A task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology
-
Rosano GM, Collins P. Gender differences in treatment of cardiovascular disease: a task force on gender of the ESC proposal on gender specific studies in cardiovascular pharmacology. Fundam Clin Pharmacol 2010;24:662-663.
-
(2010)
Fundam Clin Pharmacol
, vol.24
, pp. 662-663
-
-
Rosano, G.M.1
Collins, P.2
-
4
-
-
65349137639
-
Sex differences in pharmacokinetics and pharmacodynamics
-
Soldin OP, Mattison DR. Sex differences in pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 2009;48:143-157.
-
(2009)
Clin Pharmacokinet
, vol.48
, pp. 143-157
-
-
Soldin, O.P.1
Mattison, D.R.2
-
5
-
-
25844458971
-
Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases
-
Jochmann N, Stangl K, Garbe E, Baumann G, Stangl V. Female-specific aspects in the pharmacotherapy of chronic cardiovascular diseases. Eur Heart J 2005;26:1585-1595.
-
(2005)
Eur Heart J
, vol.26
, pp. 1585-1595
-
-
Jochmann, N.1
Stangl, K.2
Garbe, E.3
Baumann, G.4
Stangl, V.5
-
6
-
-
65849268320
-
Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials
-
Antithrombotic Trialists C, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J, Peto R, Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Zanchetti A. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009;373:1849-1860.
-
(2009)
Lancet
, vol.373
, pp. 1849-1860
-
-
Baigent, C.1
Blackwell, L.2
Collins, R.3
Emberson, J.4
Godwin, J.5
Peto, R.6
Buring, J.7
Hennekens, C.8
Kearney, P.9
Meade, T.10
Patrono, C.11
Roncaglioni, M.C.12
Zanchetti, A.13
-
7
-
-
30944467297
-
Aspirin for the primary prevention of cardiovascular events in women and men: A sex-specific meta-analysis of randomized controlled trials
-
Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006;295:306-313.
-
(2006)
JAMA
, vol.295
, pp. 306-313
-
-
Berger, J.S.1
Roncaglioni, M.C.2
Avanzini, F.3
Pangrazzi, I.4
Tognoni, G.5
Brown, D.L.6
-
8
-
-
0037206368
-
Sex-based differences in the effect of digoxin for the treatment of heart failure
-
Rathore SS, Wang Y, Krumholz HM. Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med 2002;347:1403-1411.
-
(2002)
N Engl J Med
, vol.347
, pp. 1403-1411
-
-
Rathore, S.S.1
Wang, Y.2
Krumholz, H.M.3
-
9
-
-
33749184189
-
The anti-ischemic effect of metoprolol in patients with chronic angina pectoris is gender-specific
-
Cocco G, Chu D. The anti-ischemic effect of metoprolol in patients with chronic angina pectoris is gender-specific. Cardiology 2006;106:147-153.
-
(2006)
Cardiology
, vol.106
, pp. 147-153
-
-
Cocco, G.1
Chu, D.2
-
10
-
-
0026501035
-
Metoprolol-induced reduction in postinfarction mortality: Pooled results from five double-blind randomized trials
-
Olsson G, Wikstrand J, Warnold I, Manger Cats V, McBoyle D, Herlitz J, Hjalmarson A, Sonneblick EH. Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 1992;13:28-32.
-
(1992)
Eur Heart J
, vol.13
, pp. 28-32
-
-
Olsson, G.1
Wikstrand, J.2
Warnold, I.3
Manger Cats, V.4
McBoyle, D.5
Herlitz, J.6
Hjalmarson, A.7
Sonneblick, E.H.8
-
11
-
-
0010838455
-
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group
-
Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, Torp-Pedersen C, Ball S, Pogue J, Moye L, Braunwald E. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet 2000;355:1575-1581.
-
(2000)
Lancet
, vol.355
, pp. 1575-1581
-
-
Flather, M.D.1
Yusuf, S.2
Kober, L.3
Pfeffer, M.4
Hall, A.5
Murray, G.6
Torp-Pedersen, C.7
Ball, S.8
Pogue, J.9
Moye, L.10
Braunwald, E.11
-
12
-
-
0030902115
-
Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
-
Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 1997;349:747-752.
-
(1997)
Lancet
, vol.349
, pp. 747-752
-
-
Pitt, B.1
Segal, R.2
Martinez, F.A.3
Meurers, G.4
Cowley, A.J.5
Thomas, I.6
Deedwania, P.C.7
Ney, D.E.8
Snavely, D.B.9
Chang, P.I.10
-
13
-
-
0037417252
-
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
-
Pitt B, RemmeW, Zannad F, Neaton J, Martinez F, Roniker B, Bittman R, Hurley S, Kleiman J, Gatlin M, Eplerenone Post-Acute Myocardial Infarction Heart Failure E, Survival Study I. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348:1309-1321.
-
(2003)
N Engl J Med
, vol.348
, pp. 1309-1321
-
-
Eplerenone Post-Acute Myocardial Infarction Heart Failure E1
Pitt, B.2
Remme, W.3
Zannad, F.4
Neaton, J.5
Martinez, F.6
Roniker, B.7
Bittman, R.8
Hurley, S.9
Kleiman, J.10
Gatlin, M.11
Survival Study, I.12
-
14
-
-
0033517302
-
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators
-
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
-
(1999)
N Engl J Med
, vol.341
, pp. 709-717
-
-
Pitt, B.1
Zannad, F.2
Remme, W.J.3
Cody, R.4
Castaigne, A.5
Perez, A.6
Palensky, J.7
Wittes, J.8
-
15
-
-
33750626722
-
The effect of gender on the pharmacokinetics of verapamil and norverapamil in human
-
Dadashzadeh S, Javadian B, Sadeghian S. The effect of gender on the pharmacokinetics of verapamil and norverapamil in human. Biopharm Drug Dispos 2006;27:329-334.
-
(2006)
Biopharm Drug Dispos
, vol.27
, pp. 329-334
-
-
Dadashzadeh, S.1
Javadian, B.2
Sadeghian, S.3
-
16
-
-
0037132843
-
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: A meta-analysis of all major randomised clinical trials
-
Boersma E, Harrington RA, Moliterno DJ, White H, Theroux P, Van deWerf F, de Torbal A, Armstrong PW, Wallentin LC, Wilcox RG, Simes J, Califf RM, Topol EJ, Simoons ML. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002;359:189-198.
-
(2002)
Lancet
, vol.359
, pp. 189-198
-
-
Boersma, E.1
Harrington, R.A.2
Moliterno, D.J.3
White, H.4
Theroux, P.5
Van DeWerf, F.6
De Torbal, A.7
Armstrong, P.W.8
Wallentin, L.C.9
Wilcox, R.G.10
Simes, J.11
Califf, R.M.12
Topol, E.J.13
Simoons, M.L.14
-
17
-
-
75749107064
-
Gender is an important determinant of the disposition of the loop diuretic torasemide
-
Werner U, Werner D, Heinbuchner S, Graf B, Ince H, Kische S, Thurmann P, Konig J, Fromm MF, Zolk O. Gender is an important determinant of the disposition of the loop diuretic torasemide. J Clin Pharmacol 2010;50:160-168.
-
(2010)
J Clin Pharmacol
, vol.50
, pp. 160-168
-
-
Werner, U.1
Werner, D.2
Heinbuchner, S.3
Graf, B.4
Ince, H.5
Kische, S.6
Thurmann, P.7
Konig, J.8
Fromm, M.F.9
Zolk, O.10
-
18
-
-
45249083641
-
Drug-induced long QT syndrome in women: Review of current evidence and remaining gaps
-
Hreiche R, Morissette P, Turgeon J. Drug-induced long QT syndrome in women: review of current evidence and remaining gaps. Gend Med 2008;5:124-135.
-
(2008)
Gend Med
, vol.5
, pp. 124-135
-
-
Hreiche, R.1
Morissette, P.2
Turgeon, J.3
-
19
-
-
0034672577
-
Acute electrophysiologic effect of estradiol 17beta in menopausal women
-
A1385-1386
-
Rosano GM, Leonardo F, Dicandia C, Sheiban I, Pagnotta P, Pappone C, Chierchia SL. Acute electrophysiologic effect of estradiol 17beta in menopausal women. Am J Cardiol 2000;86:1385-1387, A1385-1386.
-
(2000)
Am J Cardiol
, vol.86
, pp. 1385-1387
-
-
Rosano, G.M.1
Leonardo, F.2
Dicandia, C.3
Sheiban, I.4
Pagnotta, P.5
Pappone, C.6
Chierchia, S.L.7
|